Accelerating drug discovery with Systems Biology and Artificial Intelligence

We accelerate drug discovery by integrating experimental and computational pharmacology to reveal critical drug properties and design novel drug candidates.

The InterAx Platform

Compounds
Compounds

Compounds

Arrow left to right
Arrow left to right
Assays

The InterAx Platform

Assays

Time-resolved cellular assays

Arrow double
Arrow double
Systems biology analysis
Systems biology analysis

Systems biology analysis

Arrow split
Arrow split
Clustered Compounds
Clustered Compounds

Clustering

Arrow merge
Arrow merge
In vivo
In vivo

Better prediction of in vivo effects

Compounds

Time-resolved cellular assays

Systems biology analysis

Clustering

Better prediction of in vivo effects

InterAx helps partners to accelerate and optimize hit‑to‑lead identification for GPCRs.

With Support From

Featured News

SEP 2021

SEP 2021

Early and successful completion of European Union’s H2020 Project    September 2021, Switzerland   Today, InterAx Biotech AG, a Biotech…
APR 2021

APR 2021

InterAx Biotech further strengthens its Scientific Advisory Board – welcoming Prof. Dr. Ruedi Aebersold as a member   April 2021,…
APR 2020

APR 2020

A Spanish-Swiss Liaison to fight COVID-19

Meeting Opportunities

No event found!